 The FDA is working to address the coronavirus disease 2019 (COVID-19) outbreak and keep you and your family informed on the latest developments. Here are answers to some frequently asked questions from consumers about vaccine boosters, tests, and resources.
Q: Am I eligible for a second COVID-19 vaccine booster dose?
A: People 50 and older may receive a second booster dose of either the Pfizer-BioNTech or Moderna COVID-19 vaccine at least 4 months after receiving a first booster dose of any authorized or approved COVID-19 vaccine. View and print eligibility chart.
People 12 and older who have certain kinds of immunocompromise may receive a second booster dose. For people with certain kinds of immunocompromise, the Pfizer-BioNTech COVID-19 Vaccine is authorized for ages 12 and older, and the Moderna COVID-19 Vaccine is authorized for ages 18 and older.
The FDA-authorized Pfizer-BioNTech COVID-19 Vaccine and the FDA-approved Comirnaty can be used to provide the authorized second booster dose. Similarly, the FDA-authorized Moderna COVID-19 Vaccine and the FDA-approved Spikevax are authorized to provide the authorized second booster dose.
For more information, visit the FDA’s COVID-19 Vaccines page.
Q: What at-home over-the-counter (OTC) tests for COVID-19 are authorized by the FDA?
A: Search the list of FDA-authorized at-home over-the-counter (OTC) COVID-19 diagnostic tests.
Q: Where can I find the latest COVID-19 resources?
A: Resources to keep yourself and others safe from COVID-19 are available at COVID.gov. This toolkit is available in English, Spanish, and Simplified Chinese, and is accessible for those using assistive technologies.
These COVID-19 tools are also available by phone through the National Hotline at 1-800-232-0233 (TTY 1-888-720-7489), which supports more than 150 languages. For people with disabilities who may need additional support, the Disability Information and Access Line (DIAL) is also available to help at 1-888-677-1199 or via email at DIAL@usaginganddisability.org.
For the latest information about COVID-19, visit:
|
